Correlation Between Noble Group and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Noble Group and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Noble Group and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Noble Group Limited and Mink Therapeutics, you can compare the effects of market volatilities on Noble Group and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Noble Group with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Noble Group and Mink Therapeutics.
Diversification Opportunities for Noble Group and Mink Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Noble and Mink is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Noble Group Limited and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Noble Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Noble Group Limited are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Noble Group i.e., Noble Group and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Noble Group and Mink Therapeutics
If you would invest 0.01 in Noble Group Limited on September 14, 2024 and sell it today you would earn a total of 0.00 from holding Noble Group Limited or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.37% |
| Values | Daily Returns |
Noble Group Limited vs. Mink Therapeutics
Performance |
| Timeline |
| Noble Group Limited |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Mink Therapeutics |
Noble Group and Mink Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Noble Group and Mink Therapeutics
The main advantage of trading using opposite Noble Group and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Noble Group position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.| Noble Group vs. Mink Therapeutics | Noble Group vs. Tarsus Pharmaceuticals | Noble Group vs. Abcellera Biologics | Noble Group vs. Valneva SE ADR |
| Mink Therapeutics vs. Puma Biotechnology | Mink Therapeutics vs. Iovance Biotherapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals | Mink Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |